The company's stock drops each time the IR agent issues (re-issues) a generalized tout about the potential of VSTA's products, without reporting actual cases where the products are being used, new customers, progress on drug discovery for the company's hunt for needle in haystack.
Failure to report on specific progress is tantamount to admitting nothing new is happening. Given the company burns cash each quarter, and common holders are getting squashed under debt, its no wonder some shareholders are bailing out.
One has to wonder if the value of the IP exceeds the amount of debt.
Company hasn't helped itself with its failure to disassociate itself from bogus BGMO stock sale, making the CEO appear unethical or idiotic.
News 
Market Data 
Discover 
